All data are based on the daily closing price as of March 20, 2026
u

Universal Vision Biotechnology

3218.TWO
4.40 USD
0.02
+0.46%

Overview

Last close
4.40 usd
Market cap
372.67M usd
52 week high
8.15 usd
52 week low
4.12 usd
Target price
4.68 usd

Valuation

P/E
11.4507
Forward P/E
N/A
Price/Sales
2.8315
Price/Book Value
2.9589
Enterprise Value
339.29M usd
EV/Revenue
2.5841
EV/EBITDA
5.6754

Key financials

Revenue TTM
131.30M usd
Gross Profit TTM
77.53M usd
EBITDA TTM
60.09M usd
Earnings per Share
0.38 usd
Dividend
N/A usd
Total assets
194.12M usd
Net debt
N/A usd

About

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers wholesale and retail of medical equipment, western medicine; purchase and sale of ophthalmic surgical investments, medical optical instruments; enterprise and medical project investment and consulting services; ophthalmology diagnosis; healthcare investment management; and provides vision correction treatments, nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
  • Symbol
    3218.TWO
  • Exchange
    TWO
  • Isin
    TW0003218004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
    Ms. Shu-Hsin Lin
  • Headquarter
    Taipei
  • Web site
    https://www.uvb.com.tw/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top